# Title

 Food and Drugs. PART 510â€”NEW ANIMAL DRUGS


# ID

 CFR-2018-title21-vol6.Pt. 510


# Structured Analysis Summary

| Type        | Values                                                                                                                        |
|:------------|:------------------------------------------------------------------------------------------------------------------------------|
| Constraints | ['within', 'prior to', 'after']                                                                                               |
| Duration    | ['60.0 day', '180.0 day']                                                                                                     |
| Condition   | ['unless', 'as soon as', 'where', 'subject to', 'when', 'if']                                                                 |
| Entities    | ['Antibiotics', 'Antibiotic', 'Maintenance', 'Food', 'Rockville, MD', 'Data', 'Biologics', 'Injectable', 'Sponsor', 'Health'] |
| Date        | ['1913-03-04', '1906-06-30', '1938-06-25', '1966-08-23']                                                                      |


# Structured Analysis With Context

 


## Constraints

| Constraints   | Context                                                                                                                                   |
|:--------------|:------------------------------------------------------------------------------------------------------------------------------------------|
| prior to      | a new animal drug if at any time prior to June 25, 1938, it was subject to the                                                            |
| after         | from animals during treatment and for __ hours after the latest treatment must not be used for                                            |
| after         | taken from animals during treatment and for __hours after the latest treatment must not be used for                                       |
| after         | is adequate to prove that period of time after the latest treatment that the milk from treated                                            |
| within        | in milk from intramammary infusion preparations were requested within 60 days and the data on all other                                   |
| within        | in milk from intramammary infusion preparations were requested within 60 days and the data on all other                                   |
| within        | shown to be safe for their intended use(s) within the meaning of section 201(s) of the Federal                                            |
| prior to      | food-producing animals based on sanctions or approvals granted prior to enactment of the Food Additives Amendment of 1958                 |
| within        | additive regulations will be subject to regulatory action within 180 days after publication of the forthcoming revocation                 |
| after         | be subject to regulatory action within 180 days after  publication of the forthcoming revocation order.                                   |
| within        | (c) The required data shall be submitted  within 180 days of the date of publication of                                                   |
| within        | (c) The required data shall be submitted  within 180 days of the date of publication of                                                   |
| within        | used as directed in their labeling are needed within the 60-day period because of the importance of                                       |
| prior to      | or amend new drug or antibiotic approvals granted prior to passage of the Food Additives Amendment of 1958                                |
| within        | on which the required information is not submitted within the period of time prescribed by paragraph (c)                                  |
| within        | As soon as possible, and in any event within 15 working days of its receipt by the                                                        |
| within        | Administration has concluded that the labeling on or within packaged corticosteroid-containing preparations intended for animal use shall |
| within        | such articles are regarded as new animal drugs within the meaning of the Federal Food, Drug, and                                          |
| prior to      | an approved new animal drug application is required prior to the marketing of such preparations within the jurisdiction                   |
| within        | required prior to the marketing of such preparations within  the jurisdiction of the act.                                                 |


## Duration

| Duration   | Context                                                                                                                                                                                                                                                                    |
|:-----------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 60.0 day   | The data on the residues of antibiotics in milk from intramammary infusion preparations were requested within 60 days and the data on all other products were requested within 180 days following the date of publication of &#167;&#8201;510.112 in the Federal Register. |
| 180.0 day  | The data on the residues of antibiotics in milk from intramammary infusion preparations were requested within 60 days and the data on all other products were requested within 180 days following the date of publication of &#167;&#8201;510.112 in the Federal Register. |
| 180.0 day  | Antibiotic preparations, other than those for topical and ophthalmic application in food-producing animals, which are not covered by food additive regulations will be subject to regulatory action within 180 days after publication of the forthcoming revocation order. |
| 180.0 day  | (c) The required data shall be submitted within 180 days of the date of publication of this section in the Federal Register; except that in the case of data on intramammary infusion preparations the data shall be submitted within 60 days of such publication.         |
| 60.0 day   | (c) The required data shall be submitted within 180 days of the date of publication of this section in the Federal Register; except that in the case of data on intramammary infusion preparations the data shall be submitted within 60 days of such publication.         |
| 60.0 day   | Data demonstrating the absence in milk of residues of intramammary infusion preparations when used as directed in their labeling are needed within the 60-day period because of the importance of milk in the human diet.                                                  |


## Condition

| Condition   | Context                                                                                                                         |
|:------------|:--------------------------------------------------------------------------------------------------------------------------------|
| when        | the act shall be applicable to such terms when  used in the regulations in this part.                                           |
| if          | drug is not generally recognized, among experts qual if ied by scient                                                           |
| subject to  | time prior to June 25, 1938, it was subject to the Food and Drug Act of June 30,                                                |
| if          | drug is not generally recognized, among experts qual if ied by scient                                                           |
| when        | such drug is not a new animal drug when used in another disease or to affect another                                            |
| when        | such drug is not a new animal drug when used in another disease or to affect another                                            |
| subject to  | Biologics; products  subject to  license control.                                                                               |
| subject to  | issued thereunder shall not be deemed to be subject to section 512 of the Federal Food, Drug, and                               |
| unless      | animal feed shall be deemed to be unsafe unless at the time of its removal from the                                             |
| if          | under &#167;&#8201;515.20 of this chapter; or (2) Will, if the consignee is not the user of the                                 |
| where       | regulations published in part 558 of this chapter. where                                                                        |
| when        | regulations published in part 558 of this chapter. when                                                                         |
| unless      | be misbranded under section 502(f)(2) of the act unless their labeling bears appropriate warnings and directions for            |
| subject to  | not covered by food additive regulations will be subject to regulatory action within 180 days after publication of              |
| when        | in milk of residues of intramammary infusion preparations when used as directed in their labeling are needed                    |
| as soon as  | reports concerning any information of the following kinds: as soon as                                                           |
| where       | premises of the manufacturing establishment or the facility where  the feed labels are generated.                               |
| when        | or by injection has resulted in premature parturition when  administered during the last trimester of pregnancy.                |
| subject to  | Drugs  subject to this section are required to carry the veterinary                                                             |
| subject to  | Drugs  subject to this section are required to carry the veterinary                                                             |
| subject to  | The manufacture of medicated free-choice feeds is  subject to the current good manufacturing practice regulations in part       |
| where       | formula and/or specifications of the free-choice medicated feed, where the owner of this information requests such publication, |
| when        | for the manufacture of a free-choice medicated feed? when                                                                       |


## Entities

| Entities      | Context                                                                                                    |
|:--------------|:-----------------------------------------------------------------------------------------------------------|
| Food          | Food  and Drugs.                                                                                           |
| Health        | (b) Department means the Department of  Health  and Human Services.                                        |
| Health        | (c) Secretary means the Secretary of  Health  and Human Services.                                          |
| Food          | (d) Commissioner means the Commissioner of  Food  and Drugs.                                               |
| Sponsor       | Sponsor also means the person responsible for an investigation                                             |
| Sponsor       | Sponsor also means the person submitting or receiving approval                                             |
| Biologics     | Biologics ; products subject to license control.                                                           |
| Food          | Nonmedical Uses of Antibiotics was established by the Food and Drug Administration to study and advise the |
| Antibiotic    | Antibiotic preparations, other than those for topical and ophthalmic                                       |
| Antibiotics   | on the Veterinary Medical and Nonmedical Uses of Antibiotics , was formed by the Food and Drug             |
| Rockville, MD | Affairs, Room 15-05, Parklawn Building, 5600 Fishers Lane, Rockville, MD  20857.                           |
| Data          | Data demonstrating the absence in milk of residues of                                                      |
| Rockville, MD | Medicine, Food and Drug Administration, 7500 Standish Pl., Rockville, MD  20855.                           |
| Maintenance   | Maintenance of copies of approved medicated feed mill licenses                                             |
| Injectable    | Injectable  iron preparations.                                                                             |


## Date

| Date       | Context                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|:-----------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 1938-06-25 | (1) The composition of which is such that such drug is not generally recognized, among experts qualified by scientific training and experience to evaluate the safety and effectiveness of animal drugs, as safe and effective for use under the conditions prescribed, recommended, or suggested in the labeling thereof; except that such a drug not so recognized shall not be deemed to be a new animal drug if at any time prior to June 25, 1938, it was subject to the Food and Drug Act of June 30, 1906, as amended, and if at such time its labeling contained the same representations concerning the conditions of its use; or |
|            |               (2) The composition of which is such that such drug, as a result of investigations to determine its safety and effectiveness for use under such conditions, has become so recognized but which has not, otherwise than in such investigations, been used to a material extent or for a material time under such conditions.                                                                                                                                                                                                                                                                                                  |
| 1906-06-30 | (1) The composition of which is such that such drug is not generally recognized, among experts qualified by scientific training and experience to evaluate the safety and effectiveness of animal drugs, as safe and effective for use under the conditions prescribed, recommended, or suggested in the labeling thereof; except that such a drug not so recognized shall not be deemed to be a new animal drug if at any time prior to June 25, 1938, it was subject to the Food and Drug Act of June 30, 1906, as amended, and if at such time its labeling contained the same representations concerning the conditions of its use; or |
|            |               (2) The composition of which is such that such drug, as a result of investigations to determine its safety and effectiveness for use under such conditions, has become so recognized but which has not, otherwise than in such investigations, been used to a material extent or for a material time under such conditions.                                                                                                                                                                                                                                                                                                  |
| 1913-03-04 | An animal drug produced and distributed in full conformance with the animal virus, serum, and toxin law of March 4, 1913 (37 Stat.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 1966-08-23 | (b) Based upon an evaluation of the conclusions of said Committee and other relevant material, &#167;&#8201;510.112 was published in the Federal Register of August 23, 1966 (31 FR 11141), asking sponsors of drugs containing any antibiotic intended for use in food-producing animals to submit data to establish whether such antibiotic and its metabolites are present as residues in edible tissues, milk, and eggs from treated animals.                                                                                                                                                                                          |


